European Psychiatry: Volume 17 - Issue S1

European Psychiatry

Only show content I have access to (961)

Over 3 years (961)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

P46. Psychopharmacology - clinical

Posters, Tuesday, 7 May 2002

Correction of hyperprolactinemia under risperidon treatment

Increased use of antidepressants beneficial for depressed individuals

Cognition in elderly schizophrenic patients: risperidone vs olanzapine

Effect of smoking status on olanzapine-induced weight gain in psychosis

Efficacy and safety of a novel long-acting risperidone formulation

Long-term safety of long-acting risperidone microspheres

UKU-SERS-Pat – the UKU side effect self-rating scale

Plasma leptin and weight gain during clozapine treatment

Improvement in general life functioning with venlafaxine versus fluoxetine in outpatients with major depression

Improvement in social activity level, general life and cognitive functioning with venlafaxine versus fluoxetine in inpatients with melancholic depression

Maternal recall bias in the obstetric histories of individuals with and at increased risk of schizophrenia

P47. Psychopharmacology - experimental

Posters, Tuesday, 7 May 2002

Steroid-induced granulocytosis in neutropenic patients treated by clozapine

Gene expression profiling of human neuronal cells treated with antipsychotics in vitro

Differential distribution of (S)- and (R)- pindolol to the rat brain

Role for the endogenous cannabinoid system in addiction

Apomorphine induced motility – gender and dopamine-receptor D2-genotypes

APD-induced plasticity and ERK1/2 translocation to the nucleus

P48. Quality assurance

Posters, Tuesday, 7 May 2002

Patient satisfaction as a marker of psychiatric treatment quality — the TÜBB2000

Evaluation of psychiatric day treatment

Data base of quality in psychiatric outpatient treatment. DIPSY

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

P46. Psychopharmacology - clinical

Posters, Tuesday, 7 May 2002

P47. Psychopharmacology - experimental

Posters, Tuesday, 7 May 2002

P48. Quality assurance

Posters, Tuesday, 7 May 2002